Loading...
Hypera S.A.
HYPMY•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$4.65
$-0.22(-4.52%)
Hypera S.A. (HYPMY) Financial Performance & Income Statement Overview
Review Hypera S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-5.97%
↓ 5.97%
Operating Income Growth
-28.11%
↓ 28.11%
Net Income Growth
-18.63%
↓ 18.63%
Operating Cash Flow Growth
5.99%
↑ 5.99%
Operating Margin
7.67%
↑ 7.67%
Gross Margin
56.39%
↑ 56.39%
Net Profit Margin
12.08%
↑ 12.08%
ROE
6.73%
↑ 6.73%
ROIC
2.61%
↑ 2.61%
Hypera S.A. (HYPMY) Income Statement & Financial Overview
Review Hypera S.A.'s (HYPMY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.51B | $1.92B | $2.19B | $1.83B |
| Cost of Revenue | $724.55M | $770.19M | $855.38M | $711.35M |
| Gross Profit | $786.44M | $1.15B | $1.33B | $1.12B |
| Gross Profit Ratio | $0.52 | $0.60 | $0.61 | $0.61 |
| R&D Expenses | $22.26M | $37.97M | $45.60M | $39.70M |
| SG&A Expenses | $601.14M | $556.24M | $492.87M | $391.25M |
| Operating Expenses | $735.23M | $672.46M | $644.19M | $535.91M |
| Total Costs & Expenses | $1.48B | $1.50B | $1.50B | $1.25B |
| Interest Income | $1.04M | -$1.06M | -$1.38M | $759000.00 |
| Interest Expense | $249.16M | $259.39M | $260.90M | $273.51M |
| Depreciation & Amortization | $74.87M | $69.87M | $67.96M | $68.35M |
| EBITDA | $141.90M | $605.87M | $779.53M | $718.21M |
| EBITDA Ratio | $0.09 | $0.32 | $0.36 | $0.39 |
| Operating Income | $51.21M | $473.25M | $689.34M | $581.96M |
| Operating Income Ratio | $0.03 | $0.25 | $0.31 | $0.32 |
| Other Income/Expenses (Net) | -$210.65M | -$178.55M | -$219.18M | -$208.16M |
| Income Before Tax | -$159.44M | $294.71M | $470.17M | $373.81M |
| Income Before Tax Ratio | -$0.11 | $0.15 | $0.21 | $0.20 |
| Income Tax Expense | -$238.96M | -$75.43M | -$21.63M | -$17.74M |
| Net Income | $79.56M | $376.38M | $492.81M | $392.24M |
| Net Income Ratio | $0.05 | $0.20 | $0.23 | $0.21 |
| EPS | $0.13 | $0.59 | $0.78 | $0.62 |
| Diluted EPS | $0.13 | $0.59 | $0.77 | $0.61 |
| Weighted Avg Shares Outstanding | $633.12M | $636.89M | $632.58M | $632.93M |
| Weighted Avg Shares Outstanding (Diluted) | $647.21M | $636.25M | $637.48M | $638.13M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan